307 related articles for article (PubMed ID: 15967108)
1. SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.
Li J; Tan M; Li L; Pamarthy D; Lawrence TS; Sun Y
Neoplasia; 2005 Apr; 7(4):312-23. PubMed ID: 15967108
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation.
Zhan M; Yu D; Liu J; Glazer RI; Hannay J; Pollock RE
J Biol Chem; 2005 Feb; 280(6):4825-33. PubMed ID: 15563462
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
Li B; Lee MY
J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent repression of polo-like kinase-1 (PLK1).
McKenzie L; King S; Marcar L; Nicol S; Dias SS; Schumm K; Robertson P; Bourdon JC; Perkins N; Fuller-Pace F; Meek DW
Cell Cycle; 2010 Oct; 9(20):4200-12. PubMed ID: 20962589
[TBL] [Abstract][Full Text] [Related]
5. p53 and its downstream proteins as molecular targets of cancer.
Sun Y
Mol Carcinog; 2006 Jun; 45(6):409-15. PubMed ID: 16652354
[TBL] [Abstract][Full Text] [Related]
6. AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression.
Li J; Jiang P; Robinson M; Lawrence TS; Sun Y
Carcinogenesis; 2003 May; 24(5):827-34. PubMed ID: 12771025
[TBL] [Abstract][Full Text] [Related]
7. Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.
Li Z; Niu J; Uwagawa T; Peng B; Chiao PJ
J Biol Chem; 2005 Apr; 280(17):16843-50. PubMed ID: 15671037
[TBL] [Abstract][Full Text] [Related]
8. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
9. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
12. Radiation-inducible hSNK gene is transcriptionally regulated by p53 binding homology element in human thyroid cells.
Shimizu-Yoshida Y; Sugiyama K; Rogounovitch T; Ohtsuru A; Namba H; Saenko V; Yamashita S
Biochem Biophys Res Commun; 2001 Nov; 289(2):491-8. PubMed ID: 11716500
[TBL] [Abstract][Full Text] [Related]
13. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
14. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
15. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism.
Liedtke C; Groger N; Manns MP; Trautwein C
J Biol Chem; 2003 Jul; 278(30):27593-604. PubMed ID: 12748179
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
Gu L; Zhu N; Findley HW; Woods WG; Zhou M
J Biol Chem; 2004 Dec; 279(50):52141-9. PubMed ID: 15469934
[TBL] [Abstract][Full Text] [Related]
17. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis.
Kho PS; Wang Z; Zhuang L; Li Y; Chew JL; Ng HH; Liu ET; Yu Q
J Biol Chem; 2004 May; 279(20):21183-92. PubMed ID: 15016801
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells.
Han X; Patters AB; Chesney RW
J Biol Chem; 2002 Oct; 277(42):39266-73. PubMed ID: 12163498
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
